Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
   Patient preferences for adjuvant interferon alfa-2b treatment
   JOURNAL OF CLINICAL ONCOLOGY
   
   K.L. Kilbridge et al., "Patient preferences for adjuvant interferon alfa-2b treatment", J CL ONCOL, 19(3), 2001, pp. 812-823
2. Jonasch, E; Kumar, UN; Linette, GP; Hodi, FS; Soiffer, RJ; Ryan, BF; Sober, AJ; Mihm, MC; Tsao, H; Langley, RG; Cosimi, BA; Gadd, MA; Tanabe, KK; Souba, W; Haynes, HA; Barnhill, R; Osteen, R; Haluska, FG
   Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma
   CANCER JOURNAL
   
   E. Jonasch et al., "Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma", CANCER J, 6(3), 2000, pp. 139-145
3. Linette, GP; Shankara, S; Longerich, S; Yang, SX; Doll, R; Nicolette, C; Preffer, FI; Roberts, BL; Haluska, FG
   In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8(+) T cells in patients with melanoma
   JOURNAL OF IMMUNOLOGY
   
   G.P. Linette et al., "In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8(+) T cells in patients with melanoma", J IMMUNOL, 164(6), 2000, pp. 3402-3412
4. Yang, SX; Linette, GP; Longerich, S; Roberts, BL; Haluska, FG
   HLA-A2.1/K-b transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL
   CELLULAR IMMUNOLOGY
   
   S.X. Yang et al., "HLA-A2.1/K-b transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL", CELL IMMUN, 204(1), 2000, pp. 29-37
5. Tsao, H; Zhang, X; Fowlkes, K; Haluska, FG
   Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines
   CANCER RESEARCH
   
   H. Tsao et al., "Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines", CANCER RES, 60(7), 2000, pp. 1800-1804
6. Greenberg, DB; Jonasch, E; Gadd, MA; Ryan, BF; Everett, JR; Sober, AJ; Mihm, MA; Tanabe, KK; Ott, M; Haluska, FG
   Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes - Gabapentin may serve as a mood stabilizer
   CANCER
   
   D.B. Greenberg et al., "Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes - Gabapentin may serve as a mood stabilizer", CANCER, 89(2), 2000, pp. 356-362
7. Tsao, H; Zhang, X; Kwitkiwski, K; Finkelstein, DM; Sober, AJ; Haluska, FG
   Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma
   ARCHIVES OF DERMATOLOGY
   
   H. Tsao et al., "Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma", ARCH DERMAT, 136(9), 2000, pp. 1118-1122
8. Velculescu, VE; Madden, SL; Zhang, L; Lash, AE; Yu, J; Rago, C; Lal, A; Wang, CJ; Beaudry, GA; Ciriello, KM; Cook, BP; Dufault, MR; Ferguson, AT; Gao, YH; He, TC; Hermeking, H; Hiraldo, SK; Hwang, PM; Lopez, MA; Luderer, HF; Mathews, B; Petroziello, JM; Polyak, K; Zawel, L; Zhang, W; Zhang, XM; Zhou, W; Haluska, FG; Jen, J; Sukumar, S; Landes, GM; Riggins, GJ; Vogelstein, B; Kinzler, KW
   Analysis of human transcriptomes
   NATURE GENETICS
   
   V.E. Velculescu et al., "Analysis of human transcriptomes", NAT GENET, 23(4), 1999, pp. 387-388
9. Syngal, S; Kaptain, S; O'Neill, MJ; Isselbacher, KJ; Sober, AJ; Chung, DC; Haluska, FG
   A 50-year-old woman with severe diarrhea during radiation treatment for resected metastatic melanoma Cutaneous melanoma metastasized to the gastrointestinal tract, with protein-losing enteropathy. Adrenal cortical adenoma.
   NEW ENGLAND JOURNAL OF MEDICINE
   
   S. Syngal et al., "A 50-year-old woman with severe diarrhea during radiation treatment for resected metastatic melanoma Cutaneous melanoma metastasized to the gastrointestinal tract, with protein-losing enteropathy. Adrenal cortical adenoma.", N ENG J MED, 340(10), 1999, pp. 789-796
10. Tsao, H; Zhang, X; Majewski, P; Haluska, FG
    Mutational and expression analysis of the p73 gene in melanoma cell lines
    CANCER RESEARCH
    
    H. Tsao et al., "Mutational and expression analysis of the p73 gene in melanoma cell lines", CANCER RES, 59(1), 1999, pp. 172-174
11. Zhang, X; Tsao, H; Tsuji, T; Minoshima, S; McBride, J; Majewski, P; Todd, R; Shimizu, N; Wong, DTW; Housman, DE; Haluska, FG
    Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    X. Zhang et al., "Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene", BIOC BIOP R, 255(1), 1999, pp. 59-63
12. Gadd, MA; Cosimi, AB; Yu, J; Duncan, LM; Yu, L; Flotte, TJ; Souba, WW; Ott, MJ; Wong, LS; Sober, AJ; Mihm, MC; Haluska, FG; Tanabe, KK
    Outcome of patients with melanoma and histologically negative sentinel lymph nodes
    ARCHIVES OF SURGERY
    
    M.A. Gadd et al., "Outcome of patients with melanoma and histologically negative sentinel lymph nodes", ARCH SURG, 134(4), 1999, pp. 381-387
13. TSAO HS; ZHANG X; BENOIT E; HALUSKA FG
    IDENTIFICATION OF PTEN MMAC1 ALTERATIONS IN UNCULTURED MELANOMAS AND MELANOMA CELL-LINES/
    Oncogene
    
    H.S. Tsao et al., "IDENTIFICATION OF PTEN MMAC1 ALTERATIONS IN UNCULTURED MELANOMAS AND MELANOMA CELL-LINES/", Oncogene, 16(26), 1998, pp. 3397-3402
14. DAHIA PLM; FITZGERALD MG; ZHANG X; MARSH DJ; ZHENG ZM; PIETSCH T; VONDEIMLING A; HALUSKA FG; HABER DA; ENG C
    A HIGHLY CONSERVED PROCESSED PTEN PSEUDOGENE IS LOCATED ON CHROMOSOMEBAND 9P21
    Oncogene
    
    P.L.M. Dahia et al., "A HIGHLY CONSERVED PROCESSED PTEN PSEUDOGENE IS LOCATED ON CHROMOSOMEBAND 9P21", Oncogene, 16(18), 1998, pp. 2403-2406
15. HALUSKA FG
    ADJUVANT INTERFERON FOR STAGE-II MELANOMA
    Journal of clinical oncology
    
    F.G. Haluska, "ADJUVANT INTERFERON FOR STAGE-II MELANOMA", Journal of clinical oncology, 16(9), 1998, pp. 3205-3206
16. HALUSKA FG; HODI FS
    MOLECULAR-GENETICS OF FAMILIAL CUTANEOUS MELANOMA
    Journal of clinical oncology
    
    F.G. Haluska e F.S. Hodi, "MOLECULAR-GENETICS OF FAMILIAL CUTANEOUS MELANOMA", Journal of clinical oncology, 16(2), 1998, pp. 670-682
17. TSAO H; BENOIT E; SOBER AJ; THIELE C; HALUSKA FG
    NOVEL MUTATIONS IN THE P16 CDKN2A BINDING REGION OF THE CYCLIN-DEPENDENT KINASE-4 GENE/
    Cancer research
    
    H. Tsao et al., "NOVEL MUTATIONS IN THE P16 CDKN2A BINDING REGION OF THE CYCLIN-DEPENDENT KINASE-4 GENE/", Cancer research, 58(1), 1998, pp. 109-113
18. CHABNER BA; HALUSKA FG; TALCOTT JA
    SCREENING STRATEGIES FOR CANCER - IMPLICATIONS AND RESULTS
    JAMA, the journal of the American Medical Association
    
    B.A. Chabner et al., "SCREENING STRATEGIES FOR CANCER - IMPLICATIONS AND RESULTS", JAMA, the journal of the American Medical Association, 277(18), 1997, pp. 1475-1476
19. HALUSKA FG; THIELE C; GOLDSTEIN A; TSAO H; BENOIT EP; HOUSMAN D
    LACK OF PHOSPHOLIPASE A(2) MUTATIONS IN NEUROBLASTOMA, MELANOMA AND COLON-CANCER CELL-LINES
    International journal of cancer
    
    F.G. Haluska et al., "LACK OF PHOSPHOLIPASE A(2) MUTATIONS IN NEUROBLASTOMA, MELANOMA AND COLON-CANCER CELL-LINES", International journal of cancer, 72(2), 1997, pp. 337-339
20. TSENG JF; TANABE KK; GADD MA; COSIMI AB; MALT RA; HALUSKA FG; MIHM MC; SOBER AJ; SOUBA WW
    SURGICAL-MANAGEMENT OF PRIMARY CUTANEOUS MELANOMAS OF THE HANDS AND FEET
    Annals of surgery
    
    J.F. Tseng et al., "SURGICAL-MANAGEMENT OF PRIMARY CUTANEOUS MELANOMAS OF THE HANDS AND FEET", Annals of surgery, 225(5), 1997, pp. 544-550
21. BENOIT E; TSAO H; DRYJA TP; HALUSKA FG
    RETINOBLASTOMA TUMORS LACKING IDENTIFIED RB1 ALTERATIONS DO NOT CARRYMUTATIONS IN P16 CDKN2A OR CDK4, OTHER ELEMENTS OF THE PRB PATHWAY/
    American journal of human genetics
    
    E. Benoit et al., "RETINOBLASTOMA TUMORS LACKING IDENTIFIED RB1 ALTERATIONS DO NOT CARRYMUTATIONS IN P16 CDKN2A OR CDK4, OTHER ELEMENTS OF THE PRB PATHWAY/", American journal of human genetics, 61(4), 1997, pp. 324-324
22. HALUSKA FG; BENOIT E; HUEBNER K; HABER D; TSAO H
    INVOLVEMENT OF THE NOVEL TUMOR-SUPPRESSOR PTEN IN THE PATHOGENESIS OFMALIGNANT-MELANOMA
    American journal of human genetics
    
    F.G. Haluska et al., "INVOLVEMENT OF THE NOVEL TUMOR-SUPPRESSOR PTEN IN THE PATHOGENESIS OFMALIGNANT-MELANOMA", American journal of human genetics, 61(4), 1997, pp. 363-363
23. TSAO H; BENOIT E; HUEBNER K; THIELE C; HALUSKA FG
    IDENTIFICATION OF NOVEL MUTATIONS IN THE EXON OF CDK4 CONTAINING THE P16-BINDING REGION
    American journal of human genetics
    
    H. Tsao et al., "IDENTIFICATION OF NOVEL MUTATIONS IN THE EXON OF CDK4 CONTAINING THE P16-BINDING REGION", American journal of human genetics, 61(4), 1997, pp. 467-467
24. FLORES JF; WALKER GJ; GLENDENING JM; HALUSKA FG; CASTRESANA JS; RUBIO MP; PASTORFIDE GC; BOYER LA; KAO WH; BULYK ML; BARNHILL RL; HAYWARD NK; HOUSMAN DE; FOUNTAIN JW
    LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA
    Cancer research
    
    J.F. Flores et al., "LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA", Cancer research, 56(21), 1996, pp. 5023-5032
25. WALKER GJ; HUSSUSSIAN CJ; FLORE JF; GLENDENING JM; HALUSKA FG; DRACOPOLI NC; HAYWARD NK; FOUNTAIN JW
    MUTATIONS OF THE CDKN2 P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS/
    Human molecular genetics
    
    G.J. Walker et al., "MUTATIONS OF THE CDKN2 P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS/", Human molecular genetics, 4(10), 1995, pp. 1845-1852
26. HSU SY; KUBO M; CHUN SY; HALUSKA FG; HOUSMAN DE; HSUEH AJW
    WILMS-TUMOR PROTEIN WT1 AS AN OVARIAN TRANSCRIPTION FACTOR - DECREASES IN EXPRESSION DURING FOLLICLE DEVELOPMENT AND REPRESSION OF INHIBIN-ALPHA GENE PROMOTER
    Molecular endocrinology
    
    S.Y. Hsu et al., "WILMS-TUMOR PROTEIN WT1 AS AN OVARIAN TRANSCRIPTION FACTOR - DECREASES IN EXPRESSION DURING FOLLICLE DEVELOPMENT AND REPRESSION OF INHIBIN-ALPHA GENE PROMOTER", Molecular endocrinology, 9(10), 1995, pp. 1356-1366
27. HALUSKA FG; HOUSMAN DE
    RECENT ADVANCES IN THE MOLECULAR-GENETICS OF MALIGNANT-MELANOMA
    Cancer surveys
    
    F.G. Haluska e D.E. Housman, "RECENT ADVANCES IN THE MOLECULAR-GENETICS OF MALIGNANT-MELANOMA", Cancer surveys, 25, 1995, pp. 277-292
28. REED JA; LOGANZO F; SHEA CR; WALKER GJ; FLORES JF; GLENDENING JM; BOGDANY JK; SHIEL MJ; HALUSKA FG; FOUNTAIN JW; ALBINO AP
    LOSS OF EXPRESSION OF THE P16 CYCLIN-DEPENDENT KINASE INHIBITOR 2 TUMOR-SUPPRESSOR GENE IN MELANOCYTIC LESIONS CORRELATES WITH INVASIVE STAGE OF TUMOR PROGRESSION/
    Cancer research
    
    J.A. Reed et al., "LOSS OF EXPRESSION OF THE P16 CYCLIN-DEPENDENT KINASE INHIBITOR 2 TUMOR-SUPPRESSOR GENE IN MELANOCYTIC LESIONS CORRELATES WITH INVASIVE STAGE OF TUMOR PROGRESSION/", Cancer research, 55(13), 1995, pp. 2713-2718
29. HALUSKA FG; BRUFSKY AM; CANELLOS GP
    THE CELLULAR BIOLOGY OF THE REED-STERNBERG CELL
    Blood
    
    F.G. Haluska et al., "THE CELLULAR BIOLOGY OF THE REED-STERNBERG CELL", Blood, 84(4), 1994, pp. 1005-1019
30. FOUNTAIN JW; HALUSKA FG; GRAW SL; KAO WH; GITAI Z; BOYER L; BARNHILL R; HAYWARD NK; DRACOPOLI NC; HOUSMAN DE
    TOWARDS CLONING THE MELANOMA-ASSOCIATED TUMOR-SUPPRESSOR LOCUS ON CHROMOSOME-9P21
    Cytogenetics and cell genetics
    
    J.W. Fountain et al., "TOWARDS CLONING THE MELANOMA-ASSOCIATED TUMOR-SUPPRESSOR LOCUS ON CHROMOSOME-9P21", Cytogenetics and cell genetics, 64(2), 1993, pp. 113-114
31. FOUNTAIN JW; HALUSKA FG; GRAW SL; KAO WH; GITAI Z; BOYER LA; CASTRESANA JS; RUBIO MP; SEIZINGER B; BARNHILL R; WALKER GJ; HAYWARD NK; HOUSMAN DE
    MORE PRECISE DEFINITION OF THE 9P21 REGION LOST IN MELANOMA AND IDENTIFICATION OF A CANDIDATE GENE
    American journal of human genetics
    
    J.W. Fountain et al., "MORE PRECISE DEFINITION OF THE 9P21 REGION LOST IN MELANOMA AND IDENTIFICATION OF A CANDIDATE GENE", American journal of human genetics, 53(3), 1993, pp. 170-170
32. HALUSKA FG; GITAL Z; KAO W; HOUSMAN DE; FOUNTAIN JW
    CONSTRUCTION OF YAC CONTIGS SPANNING THE 9P21 REGION IMPLICATED IN MALIGNANT-MELANOMA
    American journal of human genetics
    
    F.G. Haluska et al., "CONSTRUCTION OF YAC CONTIGS SPANNING THE 9P21 REGION IMPLICATED IN MALIGNANT-MELANOMA", American journal of human genetics, 53(3), 1993, pp. 306-306